Icosavax’s COVID-19 shot fails to deliver in early data, spurring debate about ‘fatal flaw’ in platform
Icosavax’s COVID-19 shot fails to deliver in early data, spurring [...]
Icosavax’s COVID-19 shot fails to deliver in early data, spurring [...]
89bio gains a little more confidence in NASH treatment with [...]
AN2 upsizes IPO, teeing up bid to revitalize antibiotic let [...]
MEI rocked as FDA request for randomized data on cancer [...]
Chutes & Ladders—After 9 years at Merck, Roy Baynes follows [...]
Ligand takes a crack at a SPAC to buoy spun-off [...]
Homology gets clarity on how to resolve pheNIX gene therapy [...]
From whiteboard to white coat: Roivant Social Ventures teams up [...]
Pfizer grabs another breakthrough tag for RSV shot in older [...]
Hookipa CEO waives 50% of salary in bet on brighter [...]